Dr. David J. Horne, MD

Dr. Horne practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Horne's NPI, 1063440998, was assigned on June 29, 2006. Dr. Horne graduated from University of California, San Francisco School of Medicine in 2000. Dr. Horne holds Washington license 00044953.

Dr. Horne's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Horne's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Horne to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Horne practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Horne's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Horne is licensed in Washington.

CMS data shows 24 Medicare services from Dr. Horne across 1 procedure code in 2024, for 37 Medicare patients. Medicare paid $1,663 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Horne in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high blood pressure, and 59% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Horne's median patient age at 60, with 53% women.

In 2024, Dr. Horne wrote 40 Medicare Part D claims. 57% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $4,473 in total drug cost. In 2022, CMS named 47 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Horne for performance year 2024, reported through an alternative payment model (APM). Dr. Horne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Horne as offering telehealth.

Dmand AI links 65 papers to Dr. Horne, published from 2010 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Tuberculosis, Pulmonary, Mycobacterium tuberculosis and Tuberculosis. Dr. Horne has published most often in Clin Infect Dis. Dr. Horne's most frequent co-authors are Masahiro Narita, Kevin Patrick Fennelly, MD and Matthew John Arentz, MD.

Dmand AI links Dr. Horne to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Latent Infection, Mycobacterium avium-intracellulare Infection and Tuberculosis.

CMS Open Payments shows 4 general payments to Dr. Horne from 2 drug and device companies from 2019 to 2025. Education make up the largest share, 77% of the total. Insmed, Inc. paid the most, $132.

Dr. Horne graduated from University of California, San Francisco School of Medicine in 2000.